Skip to main content
NaltrexoneReviews home

Review of studiesNaltrexone for alcohol2014Landmark study

Garbutt 2014: who responds best to naltrexone for alcohol

Garbutt JC, Greenblatt AM, West SL, et al. Clinical and biological moderators of response to naltrexone in alcohol dependence: a systematic review of the evidence

What it found

Across 28 publications from 20 studies, a family history of alcohol problems and the Asn40Asp variant of the mu-opioid receptor gene had the strongest evidence for predicting a better response to naltrexone. Even so, the authors judged the evidence insufficient to use any predictor to guide treatment, and rated the overall risk of bias as high.

Family history linked to better response
four of five studies
OPRM1 Asn40Asp variant linked to better response
three of five studies

What they tested

Two reviewers screened 622 articles published from 1990 to April 2012 for evidence that personal or biological traits, called moderators, changed how well naltrexone worked for alcohol dependence. They rated each publication for risk of bias and judged the strength of the evidence for each trait.

28 publications covering 20 studies qualified. Most came from 12 randomized, placebo-controlled trials. The rest came from three non-randomized studies, one randomized study without a placebo, and pooled analyses of four trials.

What they found

A family history of alcohol problems was linked to better results on naltrexone in four of five studies that looked at it. The Asn40Asp variant of OPRM1, the gene for the mu-opioid receptor, was linked to better results in three of five.

Other traits reported to go with better results were being male (two of five studies), heavier drinking before treatment (two of two) and high craving (two of five).

The overall risk of bias in the published studies was high. The authors concluded that identifying who will respond to naltrexone is still in development, and that the data are not yet enough to recommend using any trait to decide treatment.

Limits

  • The authors rated the overall risk of bias in the studies as high.
  • Each trait was examined in only two to five studies.
  • The studies show links between traits and response, not proof that a trait causes a better response.

What it means if you're considering naltrexone

No test can tell you in advance whether naltrexone will work for you. This review found hints, mainly family history and one gene variant, but not enough to act on. The site's guides add that a 2020 meta-analysis of seven trials found no clear effect of that gene variant once it allowed for multiple comparisons.

Frequently asked questions

Does the OPRM1 gene predict whether naltrexone will work?

In this review, the Asn40Asp variant was linked to a better response in three of five studies. The authors judged the evidence insufficient to use for treatment decisions.

Does family history of alcoholism affect how well naltrexone works?

A family history of alcohol problems was linked to a better response in four of five studies in this review. The authors still said no trait should yet be used to choose treatment.

The paper

Garbutt JC, Greenblatt AM, West SL, et al. Clinical and biological moderators of response to naltrexone in alcohol dependence: a systematic review of the evidence. Addiction. 2014;109(8):1274-1284. doi:10.1111/add.12557

Read the reviewdoi:10.1111/add.12557

We wrote this page from the paper's published abstract, and the study's numbers here come from there. Updated October 17, 2026.

Medical disclaimer

This page is for information only and is not medical advice, diagnosis, or treatment. Don't start, stop, or change any medicine — including naltrexone — without your prescriber. Naltrexone must not be used by people taking opioid pain medicines, people dependent on opioids, or people in opioid withdrawal (FDA label). In an emergency call 911; for crisis support call or text 988. Full medical disclaimer.